nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—CYP1A1—polycystic ovary syndrome	0.804	1	CbGaD
Toremifene—ESR1—ovarian follicle—polycystic ovary syndrome	0.0204	0.321	CbGeAlD
Toremifene—CYP1A2—urine—polycystic ovary syndrome	0.00659	0.104	CbGeAlD
Toremifene—CYP3A4—urine—polycystic ovary syndrome	0.00477	0.075	CbGeAlD
Toremifene—Appetite absent—Metformin—polycystic ovary syndrome	0.00447	0.123	CcSEcCtD
Toremifene—ESR1—embryo—polycystic ovary syndrome	0.00276	0.0434	CbGeAlD
Toremifene—Rigors—Metformin—polycystic ovary syndrome	0.00272	0.0751	CcSEcCtD
Toremifene—ESR1—endometrium—polycystic ovary syndrome	0.00202	0.0318	CbGeAlD
Toremifene—ESR1—uterus—polycystic ovary syndrome	0.00186	0.0293	CbGeAlD
Toremifene—ESR1—pituitary gland—polycystic ovary syndrome	0.00183	0.0288	CbGeAlD
Toremifene—ESR1—adipose tissue—polycystic ovary syndrome	0.00182	0.0286	CbGeAlD
Toremifene—Loperamide—POMC—polycystic ovary syndrome	0.00165	0.186	CrCbGaD
Toremifene—Lethargy—Metformin—polycystic ovary syndrome	0.00165	0.0454	CcSEcCtD
Toremifene—ESR1—adrenal gland—polycystic ovary syndrome	0.00163	0.0257	CbGeAlD
Toremifene—ESR1—female gonad—polycystic ovary syndrome	0.00152	0.024	CbGeAlD
Toremifene—ESR1—vagina—polycystic ovary syndrome	0.00151	0.0238	CbGeAlD
Toremifene—Clomifene—CYP11A1—polycystic ovary syndrome	0.00151	0.17	CrCbGaD
Toremifene—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00149	0.0411	CcSEcCtD
Toremifene—Breast disorder—Metformin—polycystic ovary syndrome	0.00146	0.0402	CcSEcCtD
Toremifene—ESR1—endocrine gland—polycystic ovary syndrome	0.00142	0.0223	CbGeAlD
Toremifene—CYP1A1—uterus—polycystic ovary syndrome	0.00142	0.0223	CbGeAlD
Toremifene—CYP1A1—adipose tissue—polycystic ovary syndrome	0.00139	0.0218	CbGeAlD
Toremifene—Angina pectoris—Metformin—polycystic ovary syndrome	0.00136	0.0375	CcSEcCtD
Toremifene—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00122	0.0336	CcSEcCtD
Toremifene—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00118	0.0324	CcSEcCtD
Toremifene—CYP1A1—female gonad—polycystic ovary syndrome	0.00116	0.0182	CbGeAlD
Toremifene—CYP1A1—vagina—polycystic ovary syndrome	0.00115	0.0181	CbGeAlD
Toremifene—Phenoxybenzamine—ADRA1D—polycystic ovary syndrome	0.00111	0.125	CrCbGaD
Toremifene—CYP1A2—endocrine gland—polycystic ovary syndrome	0.00109	0.0172	CbGeAlD
Toremifene—ABCB1—embryo—polycystic ovary syndrome	0.00109	0.0172	CbGeAlD
Toremifene—CYP1A1—endocrine gland—polycystic ovary syndrome	0.00108	0.0169	CbGeAlD
Toremifene—Eye disorder—Metformin—polycystic ovary syndrome	0.00104	0.0288	CcSEcCtD
Toremifene—Angiopathy—Metformin—polycystic ovary syndrome	0.00101	0.0279	CcSEcCtD
Toremifene—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00101	0.0277	CcSEcCtD
Toremifene—Chills—Metformin—polycystic ovary syndrome	0.001	0.0276	CcSEcCtD
Toremifene—Malnutrition—Metformin—polycystic ovary syndrome	0.000972	0.0268	CcSEcCtD
Toremifene—Phenoxybenzamine—ADRA1B—polycystic ovary syndrome	0.000949	0.107	CrCbGaD
Toremifene—Vision blurred—Metformin—polycystic ovary syndrome	0.000916	0.0253	CcSEcCtD
Toremifene—Tremor—Metformin—polycystic ovary syndrome	0.000911	0.0251	CcSEcCtD
Toremifene—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000894	0.0141	CbGeAlD
Toremifene—Chest pain—Metformin—polycystic ovary syndrome	0.000828	0.0228	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000822	0.0227	CcSEcCtD
Toremifene—ABCB1—endometrium—polycystic ovary syndrome	0.000798	0.0126	CbGeAlD
Toremifene—Oedema—Metformin—polycystic ovary syndrome	0.000794	0.0219	CcSEcCtD
Toremifene—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000791	0.0124	CbGeAlD
Toremifene—Clomifene—CYP19A1—polycystic ovary syndrome	0.000782	0.0879	CrCbGaD
Toremifene—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000778	0.0215	CcSEcCtD
Toremifene—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000777	0.0214	CcSEcCtD
Toremifene—Skin disorder—Metformin—polycystic ovary syndrome	0.000771	0.0212	CcSEcCtD
Toremifene—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000767	0.0211	CcSEcCtD
Toremifene—Anorexia—Metformin—polycystic ovary syndrome	0.000757	0.0209	CcSEcCtD
Toremifene—ABCB1—uterus—polycystic ovary syndrome	0.000736	0.0116	CbGeAlD
Toremifene—ABCB1—pituitary gland—polycystic ovary syndrome	0.000723	0.0114	CbGeAlD
Toremifene—ABCB1—adipose tissue—polycystic ovary syndrome	0.00072	0.0113	CbGeAlD
Toremifene—Dyspnoea—Metformin—polycystic ovary syndrome	0.000708	0.0195	CcSEcCtD
Toremifene—Decreased appetite—Metformin—polycystic ovary syndrome	0.00069	0.019	CcSEcCtD
Toremifene—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000685	0.0189	CcSEcCtD
Toremifene—Fatigue—Metformin—polycystic ovary syndrome	0.000684	0.0189	CcSEcCtD
Toremifene—Constipation—Metformin—polycystic ovary syndrome	0.000679	0.0187	CcSEcCtD
Toremifene—Benzphetamine—ADRA1A—polycystic ovary syndrome	0.000668	0.0751	CrCbGaD
Toremifene—ABCB1—adrenal gland—polycystic ovary syndrome	0.000645	0.0101	CbGeAlD
Toremifene—Phenoxybenzamine—ADRA1A—polycystic ovary syndrome	0.000639	0.0718	CrCbGaD
Toremifene—ABCB1—female gonad—polycystic ovary syndrome	0.000602	0.00946	CbGeAlD
Toremifene—ABCB1—vagina—polycystic ovary syndrome	0.000598	0.0094	CbGeAlD
Toremifene—Clomifene—CYP1A1—polycystic ovary syndrome	0.000575	0.0647	CrCbGaD
Toremifene—Asthenia—Metformin—polycystic ovary syndrome	0.000569	0.0157	CcSEcCtD
Toremifene—Pruritus—Metformin—polycystic ovary syndrome	0.000562	0.0155	CcSEcCtD
Toremifene—ABCB1—endocrine gland—polycystic ovary syndrome	0.00056	0.0088	CbGeAlD
Toremifene—Dizziness—Metformin—polycystic ovary syndrome	0.000525	0.0145	CcSEcCtD
Toremifene—Vomiting—Metformin—polycystic ovary syndrome	0.000505	0.0139	CcSEcCtD
Toremifene—Rash—Metformin—polycystic ovary syndrome	0.0005	0.0138	CcSEcCtD
Toremifene—Dermatitis—Metformin—polycystic ovary syndrome	0.0005	0.0138	CcSEcCtD
Toremifene—Headache—Metformin—polycystic ovary syndrome	0.000497	0.0137	CcSEcCtD
Toremifene—Nausea—Metformin—polycystic ovary syndrome	0.000471	0.013	CcSEcCtD
Toremifene—Phenoxybenzamine—ADRB2—polycystic ovary syndrome	0.00038	0.0427	CrCbGaD
Toremifene—Tamoxifen—CYP19A1—polycystic ovary syndrome	0.000361	0.0406	CrCbGaD
Toremifene—Tamoxifen—CYP1A1—polycystic ovary syndrome	0.000266	0.0299	CrCbGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	9.14e-05	0.00104	CbGpPWpGaD
Toremifene—CYP1A2—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	8.98e-05	0.00103	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NPB—polycystic ovary syndrome	8.91e-05	0.00102	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	8.9e-05	0.00102	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—RPL37A—polycystic ovary syndrome	8.83e-05	0.00101	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NMNAT3—polycystic ovary syndrome	8.83e-05	0.00101	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	8.72e-05	0.000997	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	8.61e-05	0.000984	CbGpPWpGaD
Toremifene—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	8.55e-05	0.000978	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	8.42e-05	0.000963	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—AR—polycystic ovary syndrome	8.35e-05	0.000955	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	8.33e-05	0.000952	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	8.23e-05	0.000941	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	8.21e-05	0.000939	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	8.08e-05	0.000924	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—SUOX—polycystic ovary syndrome	8.07e-05	0.000923	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—LPCAT2—polycystic ovary syndrome	8.07e-05	0.000923	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	8.06e-05	0.000921	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	7.97e-05	0.000911	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—CYP19A1—polycystic ovary syndrome	7.94e-05	0.000908	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	7.88e-05	0.0009	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	7.83e-05	0.000895	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	7.76e-05	0.000887	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	7.74e-05	0.000885	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	7.66e-05	0.000875	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	7.64e-05	0.000873	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	7.58e-05	0.000866	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ISYNA1—polycystic ovary syndrome	7.51e-05	0.000858	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—POMC—polycystic ovary syndrome	7.48e-05	0.000856	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PTGER3—polycystic ovary syndrome	7.44e-05	0.00085	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—LHCGR—polycystic ovary syndrome	7.44e-05	0.00085	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	7.34e-05	0.000839	CbGpPWpGaD
Toremifene—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—polycystic ovary syndrome	7.32e-05	0.000836	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	7.3e-05	0.000835	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	7.26e-05	0.00083	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	7.05e-05	0.000806	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	7e-05	0.0008	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PTAFR—polycystic ovary syndrome	6.95e-05	0.000795	CbGpPWpGaD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	6.93e-05	0.000793	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	6.93e-05	0.000792	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	6.85e-05	0.000783	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	6.76e-05	0.000772	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	6.75e-05	0.000772	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	6.57e-05	0.000751	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	6.53e-05	0.000746	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	6.5e-05	0.000743	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	6.45e-05	0.000737	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	6.45e-05	0.000737	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—INHBB—polycystic ovary syndrome	6.4e-05	0.000732	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	6.4e-05	0.000732	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—AKR1C2—polycystic ovary syndrome	6.38e-05	0.00073	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—TEAD2—polycystic ovary syndrome	6.38e-05	0.00073	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	6.31e-05	0.000722	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	6.14e-05	0.000702	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	6.13e-05	0.0007	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	6.04e-05	0.000691	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	6.04e-05	0.000691	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	6e-05	0.000685	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PDE3B—polycystic ovary syndrome	5.98e-05	0.000683	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—YAP1—polycystic ovary syndrome	5.92e-05	0.000677	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	5.89e-05	0.000673	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	5.63e-05	0.000644	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FSHR—polycystic ovary syndrome	5.44e-05	0.000622	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—IL6—polycystic ovary syndrome	5.42e-05	0.00062	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	5.37e-05	0.000614	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PNPLA2—polycystic ovary syndrome	5.35e-05	0.000611	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	5.29e-05	0.000604	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	5.25e-05	0.0006	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	5.23e-05	0.000598	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—TNRC6B—polycystic ovary syndrome	5.22e-05	0.000597	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—PGR—polycystic ovary syndrome	5.17e-05	0.000591	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	5.15e-05	0.000589	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	5.15e-05	0.000589	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	5.12e-05	0.000585	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	5.1e-05	0.000583	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	5.1e-05	0.000583	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	5.08e-05	0.000581	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—SRD5A1—polycystic ovary syndrome	5.07e-05	0.00058	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	4.98e-05	0.000569	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	4.94e-05	0.000565	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	4.87e-05	0.000557	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FST—polycystic ovary syndrome	4.85e-05	0.000555	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—STAR—polycystic ovary syndrome	4.84e-05	0.000553	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ADRB3—polycystic ovary syndrome	4.79e-05	0.000548	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	4.79e-05	0.000547	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	4.78e-05	0.000547	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	4.77e-05	0.000545	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—LHB—polycystic ovary syndrome	4.73e-05	0.000541	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	4.71e-05	0.000539	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	4.68e-05	0.000535	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GNRH1—polycystic ovary syndrome	4.63e-05	0.000529	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	4.61e-05	0.000528	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	4.54e-05	0.000519	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	4.48e-05	0.000512	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SCT—polycystic ovary syndrome	4.44e-05	0.000507	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	4.37e-05	0.000499	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	4.34e-05	0.000497	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—HMMR—polycystic ovary syndrome	4.31e-05	0.000493	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	4.27e-05	0.000488	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.23e-05	0.000484	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	4.22e-05	0.000483	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FGF18—polycystic ovary syndrome	4.16e-05	0.000476	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	4.14e-05	0.000474	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—RBP4—polycystic ovary syndrome	4.12e-05	0.000472	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—HSD3B1—polycystic ovary syndrome	4.11e-05	0.00047	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	4.07e-05	0.000465	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	4.07e-05	0.000465	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	4.07e-05	0.000465	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	4.05e-05	0.000463	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—AR—polycystic ovary syndrome	4.02e-05	0.00046	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	3.97e-05	0.000454	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	3.97e-05	0.000454	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	3.91e-05	0.000447	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—STAR—polycystic ovary syndrome	3.86e-05	0.000442	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	3.86e-05	0.000442	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	3.85e-05	0.00044	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—YAP1—polycystic ovary syndrome	3.85e-05	0.00044	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GAB1—polycystic ovary syndrome	3.8e-05	0.000434	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—LHB—polycystic ovary syndrome	3.75e-05	0.000429	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	3.69e-05	0.000422	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	3.68e-05	0.000421	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—HSD3B2—polycystic ovary syndrome	3.67e-05	0.000419	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—INSR—polycystic ovary syndrome	3.63e-05	0.000415	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—AKR1C1—polycystic ovary syndrome	3.55e-05	0.000406	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—NCOR1—polycystic ovary syndrome	3.52e-05	0.000402	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	3.45e-05	0.000395	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.45e-05	0.000394	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	3.44e-05	0.000394	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	3.41e-05	0.00039	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.4e-05	0.000388	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PGR—polycystic ovary syndrome	3.36e-05	0.000384	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	3.29e-05	0.000376	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—SULT2A1—polycystic ovary syndrome	3.27e-05	0.000374	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—NR3C1—polycystic ovary syndrome	3.25e-05	0.000372	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	3.24e-05	0.000371	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	3.23e-05	0.00037	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—RRM2—polycystic ovary syndrome	3.16e-05	0.000362	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	3.14e-05	0.000359	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	3.14e-05	0.000359	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GHRL—polycystic ovary syndrome	3.13e-05	0.000357	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PLAT—polycystic ovary syndrome	3.13e-05	0.000357	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	3.08e-05	0.000353	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—YAP1—polycystic ovary syndrome	3.05e-05	0.000349	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	3.05e-05	0.000349	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—LHB—polycystic ovary syndrome	3e-05	0.000342	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ATF1—polycystic ovary syndrome	2.98e-05	0.000341	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NAMPT—polycystic ovary syndrome	2.93e-05	0.000335	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	2.93e-05	0.000335	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.91e-05	0.000333	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.91e-05	0.000332	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYP11A1—polycystic ovary syndrome	2.89e-05	0.000331	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.87e-05	0.000329	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	2.84e-05	0.000324	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NGFR—polycystic ovary syndrome	2.75e-05	0.000315	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	2.75e-05	0.000314	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—AKR1C3—polycystic ovary syndrome	2.73e-05	0.000312	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PRL—polycystic ovary syndrome	2.73e-05	0.000312	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYP17A1—polycystic ovary syndrome	2.69e-05	0.000308	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	2.63e-05	0.000301	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	2.62e-05	0.0003	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	2.61e-05	0.000298	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.59e-05	0.000296	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.59e-05	0.000296	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	2.53e-05	0.000289	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—PPARG—polycystic ovary syndrome	2.52e-05	0.000288	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	2.5e-05	0.000285	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.46e-05	0.000281	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	2.44e-05	0.000279	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GNAS—polycystic ovary syndrome	2.4e-05	0.000274	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	2.39e-05	0.000273	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	2.38e-05	0.000272	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	2.34e-05	0.000268	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	2.34e-05	0.000267	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—TH—polycystic ovary syndrome	2.33e-05	0.000266	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	2.31e-05	0.000264	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.29e-05	0.000261	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—SERPINE1—polycystic ovary syndrome	2.27e-05	0.000259	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—SLC2A4—polycystic ovary syndrome	2.26e-05	0.000259	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	2.26e-05	0.000259	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NRG1—polycystic ovary syndrome	2.24e-05	0.000256	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	2.18e-05	0.00025	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	2.15e-05	0.000246	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYP19A1—polycystic ovary syndrome	2.13e-05	0.000243	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	2.12e-05	0.000243	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	2.08e-05	0.000238	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	2.02e-05	0.000231	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	2.02e-05	0.000231	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	1.94e-05	0.000222	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IRS2—polycystic ovary syndrome	1.92e-05	0.00022	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GNAS—polycystic ovary syndrome	1.9e-05	0.000217	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—LEP—polycystic ovary syndrome	1.88e-05	0.000215	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	1.87e-05	0.000214	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—TH—polycystic ovary syndrome	1.86e-05	0.000213	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.86e-05	0.000212	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.85e-05	0.000211	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	1.85e-05	0.000211	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.83e-05	0.000209	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NCOR1—polycystic ovary syndrome	1.81e-05	0.000207	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	1.81e-05	0.000207	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.8e-05	0.000206	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.75e-05	0.0002	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	1.74e-05	0.000199	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	1.72e-05	0.000196	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	1.7e-05	0.000194	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IRS1—polycystic ovary syndrome	1.68e-05	0.000192	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—POMC—polycystic ovary syndrome	1.62e-05	0.000185	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1.61e-05	0.000184	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—INS—polycystic ovary syndrome	1.61e-05	0.000184	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—MTHFR—polycystic ovary syndrome	1.6e-05	0.000183	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	1.56e-05	0.000178	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IGF1—polycystic ovary syndrome	1.55e-05	0.000178	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AKT2—polycystic ovary syndrome	1.55e-05	0.000178	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	1.52e-05	0.000174	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	1.5e-05	0.000172	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—TH—polycystic ovary syndrome	1.48e-05	0.00017	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.48e-05	0.000169	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	1.45e-05	0.000165	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	1.44e-05	0.000165	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	1.44e-05	0.000165	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	1.42e-05	0.000163	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	1.37e-05	0.000157	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	1.36e-05	0.000155	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	1.35e-05	0.000154	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	1.32e-05	0.000151	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PPARG—polycystic ovary syndrome	1.3e-05	0.000148	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—POMC—polycystic ovary syndrome	1.28e-05	0.000146	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	1.28e-05	0.000146	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—INS—polycystic ovary syndrome	1.27e-05	0.000145	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	1.21e-05	0.000139	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	1.15e-05	0.000132	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—TH—polycystic ovary syndrome	1.15e-05	0.000131	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	1.11e-05	0.000127	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	1.09e-05	0.000125	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	1.05e-05	0.00012	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	1.04e-05	0.000118	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—POMC—polycystic ovary syndrome	1.02e-05	0.000117	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	1.02e-05	0.000117	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—INS—polycystic ovary syndrome	1.02e-05	0.000116	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.01e-05	0.000116	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	9.35e-06	0.000107	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	8.91e-06	0.000102	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	8.45e-06	9.66e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	8.27e-06	9.46e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	8.16e-06	9.33e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—INS—polycystic ovary syndrome	8.11e-06	9.28e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	7.87e-06	9e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL6—polycystic ovary syndrome	7.02e-06	8.02e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	6.39e-06	7.3e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	6.3e-06	7.2e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—INS—polycystic ovary syndrome	6.26e-06	7.16e-05	CbGpPWpGaD
